AbbVie Inc.ABBV

時価総額
$2939.8億
PER
60.3倍
2013年
12月31日
2014年
12月31日
2015年
12月31日
2016年
12月31日
2017年
12月31日
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
2023年
12月31日
Revenues18,79019,96022,85925,63828,21632,75333,26645,80456,19758,05454,318
Cost of products sold4,5814,4264,5005,8337,0407,7187,43915,38717,44617,41420,415
Selling, general and administrative5,3527,7246,3875,8556,2757,3996,94211,29912,34915,26012,872
Research and development2,8553,2974,2854,3664,98210,3296,4076,5577,0846,5107,675
Acquired IPR&D and milestones3383521502003274243851,200962697778
Other operating expense (income), net------890--432-56179
Total operating costs and expenses13,12616,54915,32216,25418,62426,37020,28334,44138,27339,93741,561
Operating earnings5,6643,4117,5379,3849,5926,38312,98311,36317,92418,11712,757
Interest expense, net-278-391-686-965-1,004-1,144-1,509-2,280-2,384-2,044-1,684
Net foreign exchange loss-55-678-193-303-348-24-42-71-51-148-146
Other expense, net127-13-232-513-18-3,006-5,614-2,500-2,448-4,677
Earnings before income tax expense5,3322,3696,6457,8847,7275,1978,4263,39812,98913,4776,250
Income tax expense1,2045951,5011,9312,418-490544-1,2241,4401,6321,377
Net earnings-------4,62211,54911,8454,873
Net earnings attributable to noncontrolling interest-------67910
Net earnings attributable to AbbVie Inc.4,1281,7745,1445,9535,3095,6877,8824,62211,54911,8454,873
Earnings Per Share, Basic2.581.113.153.653.313.675.32.736.486.652.73
Earnings Per Share, Diluted2.561.13.133.633.33.665.282.726.456.632.72